Current Clinical Trials
Phase III trials are underway in hepatocellular carcinoma and colorectal cancer metastatic to the liver.
| Indication | Preclinical | Phase I | Phase II | Phase III |
|---|---|---|---|---|
| Hepatocellular Carcinoma | ||||
| Metastatic Colorectal Cancer | ||||
| Glioma | ||||
| Benign Prostatic Hyperplasia | ||||
| Peripheral Arterial Disease | ||||
| Coronary Artery Disease | ||||
| Cutaneous Vascular Malformations |
LSO is focusing on three cancers for the initial development of Litx: hepatocellular carcinoma (hepatoma), metastatic colorectal cancer (MCRC), and glioblastoma multiforme (glioma). In addition to these, a clinical development program is underway to investigate the use of Litx to treat benign prostatic hyperplasia (BPH).